Lack of comparability of immunoassays for rheumatoid factor isotypes

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 61; no. 9; pp. 1619 - 1622
Main Authors Infantino, Maria, Palterer, Boaz, Pancani, Silvia, Benucci, Maurizio, Grossi, Valentina, Manfredi, Mariangela, Bizzaro, Nicola
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 28.08.2023
Walter De Gruyter & Company
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes. We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays. Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA). The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.
AbstractList Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen’s kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.OBJECTIVESRheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.METHODSWe tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).RESULTSDiagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.CONCLUSIONSThe poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes. We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays. Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA). The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.
Author Benucci, Maurizio
Grossi, Valentina
Bizzaro, Nicola
Palterer, Boaz
Infantino, Maria
Pancani, Silvia
Manfredi, Mariangela
Author_xml – sequence: 1
  givenname: Maria
  orcidid: 0000-0002-6200-4467
  surname: Infantino
  fullname: Infantino, Maria
  email: maria2.infantino@uslcentro.toscana.it
  organization: Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy
– sequence: 2
  givenname: Boaz
  surname: Palterer
  fullname: Palterer, Boaz
  organization: Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
– sequence: 3
  givenname: Silvia
  surname: Pancani
  fullname: Pancani, Silvia
  organization: IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy
– sequence: 4
  givenname: Maurizio
  surname: Benucci
  fullname: Benucci, Maurizio
  organization: Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy
– sequence: 5
  givenname: Valentina
  surname: Grossi
  fullname: Grossi, Valentina
  organization: Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy
– sequence: 6
  givenname: Mariangela
  surname: Manfredi
  fullname: Manfredi, Mariangela
  organization: Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy
– sequence: 7
  givenname: Nicola
  orcidid: 0000-0002-4227-6983
  surname: Bizzaro
  fullname: Bizzaro, Nicola
  organization: Laboratory of Clinical Pathology, San Antonio Hospital, Azienda Sanitaria Universitaria Integrata, Udine, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37027892$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1L5TAUhoMofm9dSmE2bqo5SZq2i1kMOjrCBTe6Dmk-nGjbXJMU6b83naszIOMi5HB4nvCS9wBtj340CJ0APocKqgul-qEkmNASA2630D4wWpeMUtj-M7OScwJ76CDGJ4yhqli9i_ZojUndtGQfXa2kei68LZQf1jLIzvUuzcvCDcM0ehmjnGNhfSjCbzMNMnmnCytVyhsXfZrXJh6hHSv7aI7f70P0cP3z_vJXubq7ub38sSoVretUAumoxACEMKs5t0prbCrNsSZGG6wNI00HDDrWKis7ijvA0ipFM2Yo7eghOtu8uw7-ZTIxicFFZfpejsZPUZC6bWrAnLGMfvuEPvkpjDmdIA3lDc8xIFOn79TUDUaLdXCDDLP4-J8MnG8AFXyMwdi_CGCxFCCWAsRSgFgKyAL7JCiXZHJ-TEG6_mvt-0Z7lX0yQZvHMM15-Jf6_yKHFvKhb_NRnhQ
CitedBy_id crossref_primary_10_1002_admt_202301245
Cites_doi 10.1002/art.11223
10.1002/art.30200
10.1007/s002960050069
10.1136/ard.2008.105759
10.1159/000066861
10.1136/ard.2003.019877
10.1016/j.autrev.2009.11.017
10.1136/rmdopen-2022-002817
10.1136/ard.2010.138461
10.1136/ard.61.6.505
10.1136/ard.52.2.161
10.1016/j.jtauto.2022.100142
10.3389/fimmu.2018.01113
10.3389/fimmu.2018.00876
10.1136/ard.59.2.149
10.1136/ard.2005.041376
10.1136/ard.2008.100677
10.1136/rmdopen-2021-002099
10.1136/annrheumdis-2017-212365
10.1186/s13075-016-0940-2
10.3389/fimmu.2021.685312
10.1515/cclm-2017-0988
10.1136/ard.44.1.13
ContentType Journal Article
Copyright 2023 Walter de Gruyter GmbH, Berlin/Boston.
2023 Walter de Gruyter GmbH, Berlin/Boston
Copyright_xml – notice: 2023 Walter de Gruyter GmbH, Berlin/Boston.
– notice: 2023 Walter de Gruyter GmbH, Berlin/Boston
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1515/cclm-2023-0109
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biotechnology Research Abstracts
Technology Research Database
Toxicology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Biotechnology Research Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
EndPage 1622
ExternalDocumentID 37027892
10_1515_cclm_2023_0109
10_1515_cclm_2023_01096191619
Genre Journal Article
GroupedDBID ---
0R~
0~D
29B
354
36B
4.4
53G
5GY
5RE
AAAEU
AABBZ
AAFPC
AAGVJ
AAILP
AALGR
AAOQK
AAOWA
AAPJK
AAQCX
AARRE
AASQH
AAXCG
ABAOT
ABAQN
ABDRH
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABRDF
ABUVI
ABWLS
ABXMZ
ABYBW
ACDEB
ACEFL
ACGFS
ACIWK
ACPMA
ACPRK
ACUND
ACYCL
ACZBO
ADDWE
ADEQT
ADGQD
ADGYE
ADOZN
AECWL
AEDGQ
AEGVQ
AEICA
AEJTT
AENEX
AEQDQ
AERZL
AEXIE
AFBAA
AFBDD
AFBQV
AFCXV
AFGDO
AFQUK
AFRAH
AFYRI
AGBEV
AHOVO
AHVWV
AHXUK
AIERV
AIWOI
AJATJ
AJHHK
AKXKS
ALMA_UNASSIGNED_HOLDINGS
ALUKF
ALYBR
ASYPN
BAKPI
BBCWN
BCIFA
CGQUA
CS3
DU5
EBS
EMOBN
F5P
HZ~
IY9
KDIRW
N9A
O9-
OBC
OBS
OEB
OES
OHH
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
AAYXX
CITATION
ABVMU
CGR
CUY
CVF
DBYYV
ECM
EIF
NPM
7QO
7T7
7TK
7U7
8FD
AAWFC
C1K
FR3
P64
7X8
ADNPR
ID FETCH-LOGICAL-c377t-12b3a011224fd66fcdd0e5d60d2ede0de428b141b49cfab30b10afcc3d0ee33b3
ISSN 1434-6621
1437-4331
IngestDate Thu Aug 07 15:17:40 EDT 2025
Mon Jun 30 04:31:20 EDT 2025
Wed Feb 19 02:06:48 EST 2025
Thu Apr 24 23:09:05 EDT 2025
Tue Jul 01 02:49:41 EDT 2025
Thu Jul 10 10:28:35 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords isotypes
agreement
nephelometry
rheumatoid arthritis
rheumatoid factor
Language English
License 2023 Walter de Gruyter GmbH, Berlin/Boston.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c377t-12b3a011224fd66fcdd0e5d60d2ede0de428b141b49cfab30b10afcc3d0ee33b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4227-6983
0000-0002-6200-4467
PMID 37027892
PQID 2836861121
PQPubID 105421
PageCount 04
ParticipantIDs proquest_miscellaneous_2798710644
proquest_journals_2836861121
pubmed_primary_37027892
crossref_primary_10_1515_cclm_2023_0109
crossref_citationtrail_10_1515_cclm_2023_0109
walterdegruyter_journals_10_1515_cclm_2023_01096191619
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-08-28
PublicationDateYYYYMMDD 2023-08-28
PublicationDate_xml – month: 08
  year: 2023
  text: 2023-08-28
  day: 28
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Berlin
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2023
Publisher De Gruyter
Walter De Gruyter & Company
Publisher_xml – name: De Gruyter
– name: Walter De Gruyter & Company
References 2024030716131124245_j_cclm-2023-0109_ref_003
2024030716131124245_j_cclm-2023-0109_ref_025
2024030716131124245_j_cclm-2023-0109_ref_004
2024030716131124245_j_cclm-2023-0109_ref_005
2024030716131124245_j_cclm-2023-0109_ref_006
2024030716131124245_j_cclm-2023-0109_ref_007
2024030716131124245_j_cclm-2023-0109_ref_008
2024030716131124245_j_cclm-2023-0109_ref_009
2024030716131124245_j_cclm-2023-0109_ref_020
2024030716131124245_j_cclm-2023-0109_ref_021
2024030716131124245_j_cclm-2023-0109_ref_022
2024030716131124245_j_cclm-2023-0109_ref_001
2024030716131124245_j_cclm-2023-0109_ref_023
2024030716131124245_j_cclm-2023-0109_ref_002
2024030716131124245_j_cclm-2023-0109_ref_024
2024030716131124245_j_cclm-2023-0109_ref_014
2024030716131124245_j_cclm-2023-0109_ref_015
2024030716131124245_j_cclm-2023-0109_ref_016
2024030716131124245_j_cclm-2023-0109_ref_017
2024030716131124245_j_cclm-2023-0109_ref_018
2024030716131124245_j_cclm-2023-0109_ref_019
2024030716131124245_j_cclm-2023-0109_ref_010
2024030716131124245_j_cclm-2023-0109_ref_011
2024030716131124245_j_cclm-2023-0109_ref_012
2024030716131124245_j_cclm-2023-0109_ref_013
References_xml – ident: 2024030716131124245_j_cclm-2023-0109_ref_002
  doi: 10.1002/art.11223
– ident: 2024030716131124245_j_cclm-2023-0109_ref_019
– ident: 2024030716131124245_j_cclm-2023-0109_ref_022
  doi: 10.1002/art.30200
– ident: 2024030716131124245_j_cclm-2023-0109_ref_020
  doi: 10.1007/s002960050069
– ident: 2024030716131124245_j_cclm-2023-0109_ref_006
  doi: 10.1136/ard.2008.105759
– ident: 2024030716131124245_j_cclm-2023-0109_ref_001
  doi: 10.1159/000066861
– ident: 2024030716131124245_j_cclm-2023-0109_ref_013
  doi: 10.1136/ard.2003.019877
– ident: 2024030716131124245_j_cclm-2023-0109_ref_004
  doi: 10.1016/j.autrev.2009.11.017
– ident: 2024030716131124245_j_cclm-2023-0109_ref_017
  doi: 10.1136/rmdopen-2022-002817
– ident: 2024030716131124245_j_cclm-2023-0109_ref_007
  doi: 10.1136/ard.2010.138461
– ident: 2024030716131124245_j_cclm-2023-0109_ref_023
  doi: 10.1136/ard.61.6.505
– ident: 2024030716131124245_j_cclm-2023-0109_ref_014
  doi: 10.1136/ard.52.2.161
– ident: 2024030716131124245_j_cclm-2023-0109_ref_012
  doi: 10.1016/j.jtauto.2022.100142
– ident: 2024030716131124245_j_cclm-2023-0109_ref_016
  doi: 10.3389/fimmu.2018.01113
– ident: 2024030716131124245_j_cclm-2023-0109_ref_015
  doi: 10.3389/fimmu.2018.00876
– ident: 2024030716131124245_j_cclm-2023-0109_ref_021
  doi: 10.1136/ard.59.2.149
– ident: 2024030716131124245_j_cclm-2023-0109_ref_024
– ident: 2024030716131124245_j_cclm-2023-0109_ref_003
  doi: 10.1136/ard.2005.041376
– ident: 2024030716131124245_j_cclm-2023-0109_ref_005
  doi: 10.1136/ard.2008.100677
– ident: 2024030716131124245_j_cclm-2023-0109_ref_025
  doi: 10.1136/rmdopen-2021-002099
– ident: 2024030716131124245_j_cclm-2023-0109_ref_010
  doi: 10.1136/annrheumdis-2017-212365
– ident: 2024030716131124245_j_cclm-2023-0109_ref_009
  doi: 10.1186/s13075-016-0940-2
– ident: 2024030716131124245_j_cclm-2023-0109_ref_011
  doi: 10.3389/fimmu.2021.685312
– ident: 2024030716131124245_j_cclm-2023-0109_ref_008
  doi: 10.1515/cclm-2017-0988
– ident: 2024030716131124245_j_cclm-2023-0109_ref_018
  doi: 10.1136/ard.44.1.13
SSID ssj0015547
Score 2.3860104
Snippet Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease....
SourceID proquest
pubmed
crossref
walterdegruyter
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1619
SubjectTerms Agglutination
agreement
Antibodies
Arthritis, Rheumatoid - diagnosis
Assaying
Autoantibodies
Autoimmune diseases
Chemiluminescence
Citrulline
Enzyme-Linked Immunosorbent Assay
Humans
Immunoassay
Immunoassays
Immunoglobulin A
Immunoglobulin G
Immunoglobulin Isotypes
Immunoglobulin M
Isotypes
Nephelometry
Rheumatoid arthritis
Rheumatoid Factor
Turbidimetry
Title Lack of comparability of immunoassays for rheumatoid factor isotypes
URI https://www.degruyter.com/doi/10.1515/cclm-2023-0109
https://www.ncbi.nlm.nih.gov/pubmed/37027892
https://www.proquest.com/docview/2836861121
https://www.proquest.com/docview/2798710644
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6FVuJ4qKBcgYKMhMRD5GJ7fT42IW1BaUEiQX2z9gRLwUZJDGr-BH-ZWe_6SFMQ8BJZm413M_N595sdzwxCL4XAMeOC2AH2I9t3pWcnPIhtIgNGgcxRLtU55Nl5eDrz310EF73ez85bS-WKHrL1tXEl_6NVaAO9qijZf9Bsc1NogGvQL3yChuHzr3Q8Iax5L5wsdMbtymOeqaiPAngxuazyLQwWX0QJ3LTIuKmwM8iWhTp-XXbZ6agOk2R1GbjKt2CAorzxV13xb3NJVK2JwsT9ZM0q_6Hyw2tADAuybttzputIDT5m8-_tD4YiLxnL9I3KRbbWb4jVRxIeVmesJsS7WviqAWDBHJwsykt1qVC8tb4BU_PtMNQB0oeibovaIC6zQOts7QaISWe1BbaadHZuN9Qhzlu7QlAl0GBs_tXW03WdpN3_ap__-fv0eDaZpNPxxfQG2vXA7oCFc_foZDj-1DimgH1V9XrquZs8oDDC6837b_KcLePlDtr7UYmJi89aSB1aM72L9ow9Yh1pcN1DPZHvo1ujWv_76OaZUfl99EbhzSqktYE31dDFmwV4s1q8WRpvVo23B2h2PJ6OTm1ThcNmOIpWtutRTGAXAK4neRhKxrkjAh463BNcOFyAAUtd36V-wiSh2KGuQyRjGLoJjCl-iHbyIhePkQVciPs8ApNcSl9ENCaxI0gIemNe4EW0j-xaZikzKepVpZR5qkxVkHGqZJwqGadKxn30qun_TSdn-W3Pg1oFqXmAlykw6zAO4Z-5ffSi-RrEq3xmJBdFCX2iJAYSDlZDHz3SqmuGwpFy2ydeH4VXdNmOcf10ALcKu0_-PKun6Hb7dB2gndWiFM-AAq_ocwPLX8q2tfQ
linkProvider Walter de Gruyter
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fU9QwEN7RY0b0ARVRKqh1xhmfwrVNmraPiOCpdzyBw1snP-WG48rcteMcfz0b0isI-qKvbdokm03222zyLcAHY2iutBEkpSwjLLYJKXSaE2FTJRHMSW3dPuTokA-O2beT9OTWXRh3rFKbn7NmUXuG1L6uVOM2yjquAbTAfaUm58Rl_iYutNM_rc8nD2Eld0wsPVjZ_fJp_0cXS0CDeZ1ihVFGOE_ilrrx_m9-N0338OYTWPt1HcLu2nfLEh08BbXsgz-AcrbT1HJHXd6hd_y_Tj6DtRaohrtes57DAzNdh9W9ZX64dXg0asPyL-DzUKizsLKhP9Huqb8X7sHYXT-pEKCLxTxEfBzOTk2DILka69Cn-gnH88rtA8834Phg_2hvQNr0DETRLKtJnEgqcHlAEGA151ZpHZlU80gnRptIG_RsZMxiyQplhaSRjCNhlaJYzFAq6UvoTaup2YQQjaRmOkNfzVpmMpmLPDKCxzxRSZpkMgCyHJlStdzlLoXGpHQ-DMqqdLIqnaxKJ6sAPnblLzxrx19Lbi8Humxn77xEyMVzjj2LA3jfvUbxumCKmJqqwTJZgb4mAjoWwCuvIF1VNHPx3CIJgN_RmJs6_twcdGcRghev__XDd7A6OBoNy-HXw-9b8NgrDy6F-Tb06llj3iCCquXbdopcAZX1F7A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVirlUKC0EFogSEic3I1jx0mOfS0F2ooDRdwiP2HVsqk2iartr2fcPIAWLnBNxrE9Hnu-8UxmAF5byzJtrCQJ4ynh1MUkN0lGpEu0QjCnjPP3kMcn4vCUv_-S9NGEVRdWaezXebOo2wypY1Pqxl-UDbkGUAOPtT7_Tnzlb-JdO-ML4-7CUsZplI1gaeft7sHnwZWA-vK6wgpnnAgR0y5z4-2v_K6ZbsHN-7B6ee3BHob3iyKaPADVT6GNPznbbmq1ra9uZHf8rzk-hNUOpoY7rVw9gjt2tgb39vrqcGuwfNw55R_D_pHUZ2HpwjaevU38vfAPpv7nkxLhuVxUIaLjcP7NNgiRy6kJ20I_4bQq_S1wtQ6nk4NPe4ekK85ANEvTmtBYMYmHA0IAZ4Rw2pjIJkZEJrbGRsaiXaMop4rn2knFIkUj6bRmSGYZU2wDRrNyZp9CiCrScJOipeYct6nKZBZZKaiIdZzEqQqA9AtT6C5zuS-gcV54CwZZVXhWFZ5VhWdVAG8G-os2Z8dfKbf6dS66vVsVCLhEJnBmNIBXw2tkr3elyJktG6RJc7Q0Ec7xAJ608jF0xVLvzc3jAMQNgfnZx5-Hg8YsAvD82b82fAnLH_cnxdG7kw-bsNKKDp6D2RaM6nljnyN8qtWLboP8ADjbFlc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lack+of+comparability+of+immunoassays+for+rheumatoid+factor+isotypes&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Infantino%2C+Maria&rft.au=Palterer%2C+Boaz&rft.au=Pancani%2C+Silvia&rft.au=Benucci%2C+Maurizio&rft.date=2023-08-28&rft.pub=Walter+De+Gruyter+%26+Company&rft.issn=1434-6621&rft.eissn=1437-4331&rft.volume=61&rft.issue=9&rft.spage=1619&rft.epage=1622&rft_id=info:doi/10.1515%2Fcclm-2023-0109&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon